申请人:Beecham Group p.l.c.
公开号:US04410533A1
公开(公告)日:1983-10-18
The present invention provides a compound of the formula (I): ##STR1## or a pharmaceutically acceptable salt or in-vivo hydrolyzable ester thereof wherein R.sup.1 is a hydrogen atom, an .alpha.-sulphonato-oxyethyl group, an .alpha.-sulphonato-oxypropyl group or is a group CR.sup.3 R.sup.4 R.sup.5 wherein R.sup.3 is a hydrogen atom or a hydroxy group; R.sup.4 is a hydrogen atom or a C.sub.1-6 alkyl group; and R.sup.5 is a hydrogen atom or a C.sub.1-6 alkyl group, a benzyl group, a phenyl group or is joined to R.sup.4 to form together with the carbon atom to which they are joined a carbocyclic ring of 5 to 7 carbon atoms; R.sup.2 is a pyrimidinyl group substituted by one two or three groups selected from nitro, halo, amino or substituted amino, and in addition may be optionally substituted by one or two C.sub.1-6 alkyl groups as the degree of substitution permits; and x is zero or one. These compounds are antibacterial agents. Their preparation and use are described.
本发明提供了式(I)的化合物:##STR1##或其药学上可接受的盐或体内水解酯,其中R.sup.1是氢原子,α-磺酸氧乙基基团,α-磺酸氧丙基基团或是CR.sup.3 R.sup.4 R.sup.5基团,其中R.sup.3是氢原子或羟基;R.sup.4是氢原子或C.sub.1-6烷基基团;R.sup.5是氢原子或C.sub.1-6烷基基团,苄基,苯基或与R.sup.4连接以与它们连接的碳原子一起形成5至7个碳原子的碳环的基团;R.sup.2是嘧啶基,其被从硝基,卤素,氨基或取代氨基中选择的一个、两个或三个基团取代,并且还可以根据取代程度选择性地被一个或两个C.sub.1-6烷基基团取代;x为零或一。这些化合物是抗菌剂。其制备和用途已经描述。